Results 151 to 160 of about 153,952 (350)

The Fiery Eyes of a Maenad: Origin Determination of Faceted Garnet Eye Inlays in a Roman Bronze Bust From Southern Tyrol

open access: yesArchaeometry, EarlyView.
ABSTRACT In 1837, the Tyrolean State Museum Ferdinandeum in Innsbruck, Austria, purchased a Roman bronze statue of a maenad from the 2nd century ce with red garnets as facetted eye inlays found near Brixen, Southern Tyrol. These garnets were investigated using optical microscopy, a portable hand‐held and a stationary micro‐X‐ray fluorescence device, as
H. Albert Gilg   +3 more
wiley   +1 more source

Growth and Variation in Fallow Deer (Dama dama L.) From Two Contrasting Habitats in Southern Britain

open access: yesActa Zoologica, EarlyView.
ABSTRACT We have compiled a unique data set on the age, sex, body weight and dimensions of over 500 European fallow deer from two contrasting areas of habitat in southern England: a high‐density managed parkland population and a lower‐density feral woodland one.
Adrian M. Lister, Norma G. Chapman
wiley   +1 more source

Investigating dynamics in attentive and inattentive responding together with their contextual correlates using a novel mixture IRT model for intensive longitudinal data

open access: yesBritish Journal of Mathematical and Statistical Psychology, EarlyView.
Abstract In ecological momentary assessment (EMA), respondents answer brief questionnaires about their current behaviours or experiences several times per day across multiple days. The frequent measurement enables a thorough grasp of the dynamics inherent in psychological constructs, but it also increases respondent burden.
Leonie V. D. E. Vogelsmeier   +3 more
wiley   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy